Hem/Onc Roundup: Costs of Cancer Survivorship Care, Improving Clinical Trial Disparities, and More

Insured Cancer Survivors May Still Delay Care Due to High Costs

This week on DocWire, a study found that high out-of-pocket costs may deter even insured cancer survivors from accessing follow-up care. Other frequently cited reasons for delays in care included high deductibles, high copays, inability to get time off work, or feeling nervous about seeing a health care provider.

Advertisement

https://www.docwirenews.com/urban-health-today/urban-health-picks/insured-cancer-survivors-may-still-delay-care-due-to-high-costs/

–

Predictive Tools May Help Physicians Identify Patients at Risk for Multiple Myeloma

In other news, a predictive tool may help primary care physicians identify patients at high risk of multiple myeloma. A model created based on blood test measurements was estimated to reduce the number of false alarms per diagnosis compared to testing based on the presence of comorbidities, such as anemia.

https://www.docwirenews.com/urban-health-today/urban-health-multiple-myeloma-knowledge-hub/predictive-tools-may-help-physicians-identify-patients-at-risk-for-multiple-myeloma/

–

Community-Based Engagement Initiative Yields Higher Percentage of Black Participants in Cancer Trials

A community-based engagement initiative improved enrollment of Black patients in cancer clinical trials, according to a study from the upcoming ASCO Annual Meeting. Through a combination of marketing, patient education, and partnerships with faith-based organizations and ride-share programs, the initiative was able to increase enrollment of Black patients in trials at a single institution from 11.1% in 2014 to 16.2% in 2018.

https://www.docwirenews.com/docwire-pick/hem-onc-picks/community-based-engagement-initiative-yields-higher-percentage-of-black-participants-in-cancer-trials/

–

Routine Colorectal Cancer Screening Effective in People Over 75 in Good Health

Routine colorectal cancer screening is effective for people older than 75 years old who are in otherwise good health, according to a study in JAMA Oncology. Endoscopy screening after age 75 reduced risk of cancer incidence and mortality, though these benefits were reduced in patients with cardiovascular disease or other comorbidities.

https://www.docwirenews.com/docwire-pick/hem-onc-picks/routine-colorectal-cancer-screening-effective-in-people-over-75-in-good-health/